Literature DB >> 7929344

Mammalian expression and secretion of functional single-chain Fv molecules.

C R Jost1, I Kurucz, C M Jacobus, J A Titus, A J George, D M Segal.   

Abstract

Single-chain Fv (sFv) proteins are genetically engineered molecules that consist of the two variable domains of an antibody connected by a polypeptide linker; they contain the antigen binding function of the parental protein in a single 30-kDa polypeptide chain. sFvs are usually produced in bacteria where they are insoluble and therefore require extensive refolding in vitro. In this report we followed the processing of three antibody sFvs (145-2C11 directed against murine CD3 epsilon chain, OKT9 against the human transferrin receptor, and U7.6 against dinitrophenyl groups) by transfected mammalian (COS-7) cells to determine whether the mammalian protein folding machinery can produce and secrete active sFv with high efficiency. The sFvs contained an immunoglobulin light chain leader sequence, which directed them to the endoplasmic reticulum and allowed secretion into the medium. We found that the sFvs were secreted at different rates, with the rate-limiting step of secretion being their exit from the endoplasmic reticulum. We increased the secretion rate of one of the sFvs by introducing an asparagine-linked glycosylation site in FR1 of the heavy chain, and by using tunicamycin (an inhibitor of glycosylation) we found that glycosylated antibody sFvs were secreted faster than their nonglycosylated counterparts. All secreted sFvs specifically bound their antigens; where tested, at least 90% of the secreted sFv was functional. Therefore, mammalian cells can effectively fold and secrete sFv antibody and can provide a convenient system for testing and producing sFv proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929344

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Engineered Antibody Fragments for Immunodiagnosis of Papaya ringspot virus.

Authors:  Yogita Maheshwari; H N Verma; R K Jain; Bikash Mandal
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

3.  Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.

Authors:  J H Richardson; J G Sodroski; T A Waldmann; W A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

4.  An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation.

Authors:  G Tell; A Zecca; L Pellizzari; P Spessotto; A Colombatti; M R Kelley; G Damante; C Pucillo
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

Review 5.  Orchestration of secretory protein folding by ER chaperones.

Authors:  Tali Gidalevitz; Fred Stevens; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2013-03-15

6.  Expression of anti human IL-4 and IL-6 scFvs in transgenic tobacco plants.

Authors:  P Ehsani; A Meunier; F Nato; A Jafari; A Nato; P Lafaye
Journal:  Plant Mol Biol       Date:  2003-05       Impact factor: 4.076

7.  Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.

Authors:  D M Kranz; T A Patrick; K E Brigle; M J Spinella; E J Roy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

8.  High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells.

Authors:  Allissia A Gilmartin; Benjamin Lamp; Till Rümenapf; Mats A A Persson; Félix A Rey; Thomas Krey
Journal:  Protein Eng Des Sel       Date:  2011-12-12       Impact factor: 1.650

9.  Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.

Authors:  M P Deonarain; A A Epenetos
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

10.  Synthesis of sialoglycopolypeptide for potentially blocking influenza virus infection using a rat alpha2,6-sialyltransferase expressed in BmNPV bacmid-injected silkworm larvae.

Authors:  Makoto Ogata; Makoto Nakajima; Tatsuya Kato; Takakiyo Obara; Hirokazu Yagi; Koichi Kato; Taichi Usui; Enoch Y Park
Journal:  BMC Biotechnol       Date:  2009-06-05       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.